1155847-48-5

Basic information

• Product Name: 3-chloro-5-[(4-chloro-2-hydroxypyridin-3-yl)oxy]benzonitrile
• Synonyms: 3-chloro-5-[(4-chloro-2-hydroxypyridin-3-yl)oxy]benzonitrile
• CAS NO: 1155847-48-5
• Molecular Weight: 281.098
• Mol File: 1155847-48-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3-chloro-5-[(4-chloro-2-hydroxypyridin-3-yl)oxy]benzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 3-chloro-5-[(4-chloro-2-hydroxypyridin-3-yl)oxy]benzonitrile(1155847-48-5)
• EPA Substance Registry System: 3-chloro-5-[(4-chloro-2-hydroxypyridin-3-yl)oxy]benzonitrile(1155847-48-5)

Safety Data

• Hazardous Substances Data: 1155847-48-5(Hazardous Substances Data)

Upstream product

• 1155847-46-3 3-[(2-amino-4-chloropyridin-3-yl)oxy]-5-chlorobenzonitrile 
• 1155847-42-9 2-bromo-4-chloro-3-fluoropyridine 
• 1155847-43-0 4-chloro-3-fluoropicolinonitrile 
• 1155847-61-2 3-(3-bromo-5-chlorophenoxy)-4-chloropyridine-2-carbonitrile 
• 1155847-44-1 3-(3-bromo-5-chlorophenoxy)-4-chloropyridine-2-carboxylic acid 
• 1155847-45-2 tert-butyl [3-(3-bromo-5-chlorophenoxy)-4-chloropyridin-2-yl]carbamate 
• 2546-56-7 4-chloro-3-fluoro-pyridine 
• 1338226-09-7 3-(3-bromo-5-chlorophenoxy)-2,4-dichloropyridine 
• 101664-56-6 2-Chlor-3-fluor-4-nitropyridin-1-oxid 
• 1338226-08-6 3-(3-bromo-5-chlorophenoxy)-2-chloro-4-nitropyridine-1-oxide 
• 56962-04-0 3-bromo-5-chlorophenol 

Downstream Products

• 1155847-49-6 3-chloro-5-[(4,5-dichloro-2-oxo-1,2-dihydropyridin-3-yl)oxy]benzonitrile 
• 1155846-77-7 3-chloro-5-{[4-chloro-2-oxo-1-(1H-pyrazolo[3,4-b]pyridin-3-ylmethyl)-1,2-dihydropyridin-3-yl]oxy}benzonitrile 
• 1155847-49-6 C₁₂H₅Cl₃N₂O₂ 
• 1155846-78-8 C₁₉H₁₂Cl₂N₆O₂ 
• 1155846-79-9 3-({1-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methyl]-4-chloro-2-oxo-1,2-dihydropyridin-3-yl}oxy)-5-chlorobenzonitrile trifluoroacetate 

Relevant articles and documents

Design and synthesis of pyridone inhibitors of non-nucleoside reverse transcriptase

Next generation NNRTIs are sought which possess both broad spectrum antiviral activity against key mutant strains and a high genetic barrier to the selection of new mutant viral strains. Pyridones were evaluated as an acyclic conformational constraint to

NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS

Heteroaromatic compounds of Formula (I), are HIV reverse transcriptase inhibitors, wherein ring A is: (ii-a), (ii-b), (ii-c), (ii-d), or (ii-e); and wherein n, L, M, U, X, Y, Z, RE, RF, R1, R2A, R2B,